health canada approval zepbound tirzepatide obesity canada 2024 2025 🇨🇦 has approved for the treatment of obstructive sleep apnea in adults living with obesity, making it the first and only GLP-1 medication in approved for the sleep Diabetes Canada 2024 Pharmacotherapy Guidelines

Description

Questions we hear everyday Do I need to make changes to my diet with Compound Tirzepatide

Potential Benefits of Tirzepatide Consistent Hormone Balance Bioidentical hormone replacement therapy pellets release a steady dose of hormones, avoiding the fluctuations common with pills or injections

Participants who continued tirzepatide kept losing weight

Explore life-changing weight loss possibilities with comprehensive support and care, all orchestrated effortlessly from home

Nausea Diarrhea Vomiting Constipation Abdominal pain Headache Fatigue Dyspepsia Dizziness Abdominal distension Eructation Hypoglycemia in patients with type 2 diabetes Flatulence Gastroenteritis Gastroesophageal reflux disease You are encouraged to report negative side effects of prescription products: Contact FDA MedWatch at 1-800-FDA-1088 or visit www.fda.gov/medwatch